One or two intact local summaries. No averaged regimen, patient-specific dose or automatic source preference.
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
Historical H. pylori regimens, the pediatric weight table and lifelong MAC statement are preserved from the source; they are not independently verified current treatment recommendations. IR and XL are distinct formulations.
The handbook renal dose ranges and selected U.S. label dose-reduction rules differ. Current label instructions and patient-specific interactions must be reviewed; the sources are not counted as agreeing.
Sinusitis: 500 mg every 12 hours for 14 days. Community-acquired pneumonia: 250 mg every 12 hours for 7-14 days. For disseminated MAC treatment, 500 mg every 12 hours with other antimycobacterial agents. These are label regimens, not endorsement as current empiric first-line choices.
clarithromycin:dm-98580dee-d2f4-4f62-a2d4-7434bab2421e-1 · Source locator: 2.2, Table 1; 2.5
At CrCl <30 mL/min, reduce the selected dose by 50%. With atazanavir or a ritonavir-containing regimen, the renal table calls for a 50% reduction at CrCl 30-60 and a 75% reduction below 30. Atazanavir itself requires a 50% reduction. Do not combine independently calculated reductions.
clarithromycin:dm-98580dee-d2f4-4f62-a2d4-7434bab2421e-2 · Source locator: 2.6, Table 2; 2.7
Concomitant colchicine is contraindicated in renal or hepatic impairment. Review the complete interaction and QT-risk warnings before selecting therapy.
clarithromycin:dm-98580dee-d2f4-4f62-a2d4-7434bab2421e-3 · Source locator: 4.4; 5.2; 7
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
Pinned reference: https://globalrph.com/blogCalcs/renal-dosing-master/compare.php?id=clarithromycin&s1=dm-98580dee-d2f4-4f62-a2d4-7434bab2421e&h1=a904c68455ab18ab19761fdc990683d809b4cd67a1bafa0f4b6311a180998967